Khurram Jamil Galectin Therapeutics Inc (GALT) insider trading activity
Khurram Jamil is Chief Medical Officer of GALECTIN THERAPEUTICS INC. Currently has a direct ownership of 0 shares of GALT, which is worth approximately $0. The most recent transaction as insider was on Jan 06, 2026, when has been sold 21,446 shares (Common Stock) at a price of $3.65 per share, resulting in proceeds of $78,277. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
100.0%
3M change
100.0%
12M change
Total Value Held
$0
Khurram Jamil Transaction History
KJ
Khurram Jamil
Chief Medical Officer
Newtown, PA